Research analysts at Zacks Research reduced their Q1 2026 EPS estimates for shares of GSK in a report issued on Wednesday, ...

With Pfizer’s stock down sharply, an activist investor is pushing for something new from the CEO who spurred the company to ...

The Phase IIa study (NCT06235905) met its primary endpoint – showing a clinically meaningful improvement of -6.1 on the ...

The vaccine that’s helped protect millions of people worldwide from the COVID-19 virus and its variants would not have been ...

A large new study says the RSV vaccine is 80% effective at preventing hospitalization in older adults due to complications from the illness, and works just as well at protecting them from death or ...

Considering the reasons behind the jump in licensing deal values, Chan added: “Licensing agreement deal values for mRNA-based ...

London-based GSK is crossing the pond to form a new lung disease research collaboration with Boston scientists. | ...

Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...

With the appointment of Christian Tucat as CEO, Sciensus aims to leverage insights and expand its global reach in delivering lifesaving drugs and therapies.

The global malaria treatment market is projected to be valued at approximately USD 1.8 billion in the fiscal year 2023, an ...

The job sector in the United Kingdom provides numerous chances for international workers, particularly via the UK Work Visa. According to Last Stop Booking, the average monthly income for positions in ...